Posted in | News

U.S. Concrete Acquires Assets of DuBrook Concrete Located in Greater Washington

U.S. Concrete, Inc. announced today that it has acquired the assets of DuBrook Concrete, Inc. ("DuBrook"), in Chantilly, VA., located within the greater Washington, D.C. metropolitan area.

Dubrook manufactures and delivers ready-mixed concrete in the northern Virginia market through its three ready-mixed concrete batch plants and fleet of 42 mixer trucks. The addition of DuBrook significantly increases U.S. Concrete's service footprint throughout the Washington, D.C. metropolitan area.

"We are pleased to complete this acquisition within one of our targeted growth regions with strong expected future demand," said U.S. Concrete President and CEO, William J. Sandbrook. "DuBrook is a great complement to our existing operations and further strengthens our local customer relationships by providing a more robust service footprint. We expect this transaction to be immediately accretive to our business as we integrate DuBrook's operations into our platform and capitalize on the growing commercial and residential project opportunities in the Washington, D.C. metropolitan area."

About U.S. Concrete, Inc.
U.S. Concrete, Inc. (the "Company" or U.S. Concrete) serves the construction industry in several major markets in the United States through its two business segments: ready-mixed concrete and aggregate products. The Company has 140 standard ready-mixed concrete plants, 16 volumetric ready-mixed concrete facilities, and 10 producing aggregates facilities. During 2014, U.S. Concrete sold approximately 5.7 million cubic yards of ready-mixed concrete and approximately 4.7 million tons of aggregates. For more information on U.S. Concrete, visit www.us-concrete.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.